TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

Sienna Biopharmaceuticals

Sell-side

Exclusive Financial Advisor, December 2019

Sienna Biopharmaceuticals
Sale of Certain Assets to Sebacia, Inc.

Sienna is a clinical-stage biopharmaceutical company created to bring unconventional scientific innovations to patients whose lives remain burdened by their disease.

More Like This

Jul 2023

Sold Majority Stake in hg medical to Astorg Mid-Cap

Exclusive Financial Advisor

View Details >
May 2023
Jounce Therapeutics Logo

Acquired by Concentra Biosciences

Exclusive Financial Advisor

View Details >
Mar 2023

Smile Source, a Portfolio Company of Brazos Private Equity Partners, has Partnered with Incline Equity Partners

Exclusive Financial Advisor

View Details >